drugset / Trial / NCT00094081

Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer

NCT00094081

Phase 3 Completed 861 enrolled Sanofi
RandomizedParallel-groupOpen-labelTreatment

Summary

The trial will compare the efficacy and safety of concomitant chemoradiation with tirapazamine, cisplatin and radiation versus cisplatin and radiation.

Timeline

Start
2002-10
Primary completion
2006-09
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 75 mg/m2
Subject Cisplatin Other / unclassified 100 mg/m2
Subject tirapazamine Small molecule